# Enterprise Readiness

## Objective

Answer, in one place, whether LumenAI is ready for enterprise adoption by
hospitals, health systems, manufacturers, and strategic partners — and
point to the detailed evidence for each dimension rather than restating
it.

This document does not change the clinical architecture (frozen per
Phase 19.5, `docs/architecture/`). It assesses the platform's readiness
to be deployed, trusted, supported, and scaled.

## Readiness dimensions

| Dimension | Status | Evidence |
|---|---|---|
| **Deployment** | Ready — documented paths for managed cloud and customer-managed infrastructure | `docs/enterprise/deployment-framework.md`, `docs/deployment/` |
| **Security & compliance** | Ready — RBAC, JWT/OIDC, tenant isolation, audit logging, encryption, incident response all documented and enforced in code | `docs/security/security-compliance-center.md` |
| **AI governance** | Ready — model lifecycle, dataset governance, shadow mode, and human-gated promotion all implemented (Phase 17) | `docs/enterprise/ai-governance.md` |
| **Clinical safety** | Ready — human-in-the-loop enforced structurally, not just by policy; known limitations documented honestly | `docs/enterprise/clinical-safety.md` |
| **Commercial packaging** | Ready — four editions defined with clear feature/limit boundaries | `docs/enterprise/commercial-packaging.md` |
| **ROI measurement** | Ready — real, live-data ROI computation; industry-benchmark fallback clearly labeled as such | `docs/enterprise/roi-framework.md` |
| **Customer success** | Ready — 30/60/90-day plans, training matrix, health scoring | `docs/enterprise/customer-success-framework.md` |
| **Clinical evidence** | Framework ready; live multi-site validation pending | `docs/evidence/` |
| **Regulatory readiness** | Gap-analysis stage — see `docs/regulatory/qms-readiness-gap-analysis.md`, `docs/regulatory/fda-submission-readiness-checklist.md` | Not yet submission-ready; explicitly tracked |

## What "enterprise-ready" means here

It means an enterprise buyer's evaluation team — IT security, legal,
clinical leadership, procurement — can get a complete, honest answer to
every question they'll ask, sourced from real documentation and real,
tested code, without needing an engineer in the room. It does not mean
every future capability (full anatomy segmentation, predictive
maintenance, FDA clearance) is already built — see
`docs/architecture/future-ai-roadmap.md` and `VERSION_1_0.md`'s Known
Limitations section for what's explicitly out of scope for this release.

## Enterprise readiness gate

Before offering LumenAI to a new enterprise customer segment (a new
edition tier, a new geography, a new partner type), confirm:

- [ ] The relevant deployment guide exists and has been exercised at
  least once in staging (`docs/deployment/enterprise-installation-guide.md`)
- [ ] The security review for that deployment model is current
  (`docs/security/security-compliance-center.md`)
- [ ] The commercial packaging tier covers the customer's expected scale
  (`docs/enterprise/commercial-packaging.md`)
- [ ] Support commitments match what's actually staffed
  (`docs/enterprise/customer-success-framework.md`)
- [ ] No known limitation (`VERSION_1_0.md`) is being misrepresented to
  the prospective customer

## Ownership

Enterprise readiness spans engineering, security, clinical, and
commercial teams — no single team should sign off alone. This document is
the shared reference all of them should be working from.
